Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Otoferlin gene therapy restores hearing in congenital deafness model

May 18, 2020

Autifony Therapeutics identifies new K(V)3 potassium channel modulators

April 30, 2020

Fetal pharmacotherapy in the developing inner ear may rescue congenital deafness

April 22, 2020

Novel motheaten spontaneous mutation mouse model of otitis media

Feb. 5, 2020

Gerbil model of cholesteatoma developed to test oncolytic HSV potential

Feb. 4, 2020

Proof-of-concept study of SENS-111 in acute unilateral vestibulopathy misses primary endpoint

Dec. 2, 2019

Novel gamma-secretase inhibitor PIPE-505 restores synaptic function, regenerates outer hair cells

Oct. 23, 2019

Frequency Therapeutics initiates dosing in phase IIa study of FX-322

Oct. 11, 2019

Otonomy announces initiation of phase I/II study of OTO-413

Sep. 18, 2019

FDA and EMA offer Auris Medical guidance on phase II/III trial with Keyzilen

Sep. 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...